Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net income	$ 4,188	$ 5,716
Increase (decrease) in cash from operating assets and liabilities:
Accounts receivable	(487)	(1,312)
Inventories and other assets	53	(333)
Accounts payable and accrued expenses	(644)	731
Depreciation and amortization	2,219	2,125
Income taxes	159	185
Losses (gains) on sales of facilities	25	(1,057)
Losses on retirement of debt	78	12
Amortization of debt issuance costs and discounts	22	21
Share-based compensation	258	341
Other	124	87
Net cash provided by operating activities	5,995	6,516
Cash flows from investing activities:
Purchase of property and equipment	(3,072)	(2,385)
Acquisition of hospitals and health care entities	(176)	(488)
Sales of hospitals and health care entities	652	1,980
Change in investments	10	(38)
Other	(10)	2
Net cash used in investing activities	(2,596)	(929)
Cash flows from financing activities:
Issuance of long-term debt	5,976	4,337
Net change in revolving credit facilities	(230)	500
Repayment of long-term debt	(2,774)	(3,787)
Distributions to noncontrolling interests	(550)	(501)
Payment of debt issuance costs	(53)	(38)
Payment of dividends	(497)	(476)
Repurchase of common stock	(5,481)	(6,143)
Other	(209)	(241)
Net cash used in financing activities	(3,818)	(6,349)
Effect of exchange rate changes on cash and cash equivalents	(33)	(4)
Change in cash and cash equivalents	(452)	(766)
Cash and cash equivalents at beginning of period	1,451	1,793
Cash and cash equivalents at end of period	999	1,027
Interest payments	1,329	1,127
Income tax payments, net	$ 931	$ 1,346